A detailed history of Plan A Wealth LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Plan A Wealth LLC holds 10,625 shares of MYGN stock, worth $67,256. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,625
Holding current value
$67,256
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$3.84 - $7.84 $40,800 - $83,300
10,625 New
10,625 $76.8 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $510M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Plan A Wealth LLC Portfolio

Follow Plan A Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plan A Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plan A Wealth LLC with notifications on news.